Figure 3.

Development of a novel scaffold for IL-6 inhibitors through the combination of natural product-inspired analogue development and computer-aided drug repositioning of bazedoxifene. Key scaffold components are color coded. Blue indicates hydrophobic fragments for engaging with the gp130-D1 hydrophobic pocket, purple denotes rings which engage in π–π interactions with TYR94, and red denotes chains participating in hydrogen bonding with ASN92 and/or hydrophobic interactions with a shallow subpocket adjacent to ASN92.